Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Nos. 333-161751 and 333-161751-01
June 21, 2012
BioMed Realty, L.P.
$250,000,000 4.25% Senior Notes due 2022
fully and unconditionally guaranteed by
BioMed Realty Trust, Inc.
| Issuer: | BioMed Realty, L.P. | |||
| Guarantor: | BioMed Realty Trust, Inc. | |||
| Ratings: (Moody’s / S&P)* | Baa3 / BBB- | |||
| Security Type: | Senior Unsecured Notes | |||
| Principal Amount: | $250,000,000 | |||
| Pricing Date: | June 21, 2012 | |||
| Settlement Date: | June 28, 2012 (T+5) | |||
| Maturity Date: | July 15, 2022 | |||
| Interest Payment Dates: | January 15 and July 15, beginning January 15, 2013 | |||
| Benchmark: | 1.75% due May 15, 2022 | |||
| Benchmark Price / Yield: | 101-9+ / 1.608% | |||
| Spread to Benchmark: | +275 bps | |||
| Yield to Maturity: | 4.358% | |||
| Coupon: | 4.25% | |||
| Public Offering Price: | 99.126% | |||
| Redemption Provisions: | At any time before 90 days prior to maturity at the Adjusted Treasury Rate plus 45 bps. If the notes are redeemed on or after 90 days prior to the maturity date, the redemption price will be 100% of the principal amount of the notes being redeemed. | |||
| CUSIP / ISIN: | 09064A AG6 / US09064AAG67 | |||
| Joint Book-Running Managers: | Wells Fargo Securities, LLC | |||
| KeyBanc Capital Markets Inc. | ||||
| Morgan Stanley & Co. LLC UBS Securities LLC | ||||
| Co-Managers: | Deutsche Bank Securities Inc. | |||
| U.S. Bancorp Investments, Inc. PNC Capital Markets LLC | ||||
| Raymond James & Associates, Inc. | ||||
| SMBC Nikko Capital Markets Limited Comerica Securities, Inc. The Huntington Investment Company Mitsubishi UFJ Securities (USA), Inc. Santander Investment Securities Inc. | ||||
| TD Securities (USA) LLC | ||||
*Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.
The issuer has filed a registration statement (including a preliminary prospectus supplement and a prospectus) with the Securities and Exchange Commission (SEC) for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement for this offering, the issuer’s prospectus in that registration statement and any other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by searching the SEC online data base (EDGAR) on the SEC web site at http://www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus supplement and prospectus if you request it by calling Wells Fargo Securities, LLC toll-free at 1-800-326-5897.